Literature DB >> 5771588

Hypokalaemia complicating carbenoxolone (duogastrone) therapy.

A Muir, J A Laithwaite, W Wood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5771588      PMCID: PMC1983413          DOI: 10.1136/bmj.2.5655.512-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

Review 1.  Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.

Authors:  D W Piper; T R Heap
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Complications of carbenoxolone therapy.

Authors:  G J Davies; J Rhodes; B J Calcraft
Journal:  Br Med J       Date:  1974-08-10

3.  Duogastrone-induced hypokalaemic nephropathy and myopathy with myoglobinuria.

Authors:  A B Mitchell
Journal:  Postgrad Med J       Date:  1971-12       Impact factor: 2.401

4.  [Influence of carbenoxolone therapy on the renin-angiotensin-aldosterone system].

Authors:  C Werning; O Stadelmann; S E Miederer; W Vetter; H U Schweikert; D Stiel; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1971-12-01

5.  Hypokalaemic myopathy and myoglobinuria due to carbenoxolone sodium.

Authors:  P C Barnes; J H Leonard
Journal:  Postgrad Med J       Date:  1971-12       Impact factor: 2.401

Review 6.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Hypokalaemic paralysis due to carbenoxolone.

Authors:  J Rankin; M E Scott
Journal:  Ulster Med J       Date:  1973
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.